Clinical Trials Directory

Trials / Completed

CompletedNCT01885065

Efficacy of Novel Edible Gel-based Artificial Saliva in Cancer Patients

Efficacy Study of Novel Edible Gel-based Artificial Saliva in Xerostomic Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Dental Innovation Foundation Under Royal Patronage · Academic / Other
Sex
All
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether continuous use of edible, gel-based artificial saliva in cancer patients with dry mouth problems will reduce signs and symptoms of dry mouth and improve quality of patients' saliva.

Conditions

Interventions

TypeNameDescription
OTHERGel-based artificial salivaGel-based artificial saliva is an edible non-nutritious gel intended to relieve dry mouth. Taking orally 1-2 teaspoon each time, 5 times / day (30-50 ml/ day) for four weeks.

Timeline

Start date
2012-07-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2013-06-24
Last updated
2013-06-24

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01885065. Inclusion in this directory is not an endorsement.